IP17: Prostate Cancer: Localized: Surgical Therapy I
Friday, May 15, 2026 1:00 PM to 3:00 PM · 2 hr. (America/New_York)
147A
Poster and Podium Sessions
Oncology: Prostate
Friday, May 15
IP17-01: Impact of Intravesical Prostatic Protrusion on Continence Outcomes Following Single-Port Transvesical Radical Prostatectomy
Friday, May 15, 2026 1:00 PM to 3:00 PM
147A
IP17-02: Optimizing PSA Follow-Up After Radical Prostatectomy: A Population-Based Analysis of Biochemical Recurrence Patterns
Friday, May 15, 2026 1:00 PM to 3:00 PM
147A
Francesco Pellegrino · IRCCS San Raffaele
IP17-03: Integrating Preoperative PSMA-PET and MRI Findings to Predict Nodal Metastasis in Prostate Cancer Patients Undergoing Prostatectomy
Friday, May 15, 2026 1:00 PM to 3:00 PM
147A
IP17-04: Saline-Assisted Fascial Engorgement (SAFE) Nerve Preservation Guided by Micro-Ultrasound During Robotic Radical Prostatectomy: Interim Analysis of a Phase III Randomized Controlled Trial
Friday, May 15, 2026 1:00 PM to 3:00 PM
147A
IP17-05: Erectile Function Outcomes After Menon Precision Prostatectomy: Analyzing Predictors of Functional Recovery and Evidence of Reproducibility of Outcomes
Friday, May 15, 2026 1:00 PM to 3:00 PM
147A
IP17-06: Omitting Pelvic Lymph Node Dissection in Prostate Cancer Patients with Negative PSMA-PET/CT: A Multicenter Study Challenging Current Nomogram Recommendations
Friday, May 15, 2026 1:00 PM to 3:00 PM
147A
Fabio Zattoni · University of Udine, Italy
IP17-07: The RoboSling randomised controlled trial - continence outcomes with autologous vascularised bladder neck sling during robotic radical prostatectomy
Friday, May 15, 2026 1:00 PM to 3:00 PM
147A
IP17-08: Evaluating Efficacy of Surgical Intervention Against Combination Radiation and Androgen Deprivation Therapy for men with Locally Advanced Prostate Cancer: An NCDB Analysis
Friday, May 15, 2026 1:00 PM to 3:00 PM
147A
IP17-09: Mortality after radical treatment of non-metastatic prostate cancer: A population-based cohort study
Friday, May 15, 2026 1:00 PM to 3:00 PM
147A
IP17-10: Initial Outcomes Assessing Margin Status After Robot-Assisted Prostatectomy Using a Real-Time Digital Microscopy Device
Friday, May 15, 2026 1:00 PM to 3:00 PM
147A
IP17-11: Accuracy of Indocyanine Green Fluorescence in Detecting Lymph Node Metastases in High-Risk Prostate Cancer
Friday, May 15, 2026 1:00 PM to 3:00 PM
147A
IP17-12: Refining patient selection for salvage radical prostatectomy beyond EAU recommendations: development of a nomogram to estimate metastasis-free survival
Friday, May 15, 2026 1:00 PM to 3:00 PM
147A
Alessandro Marquis · City of Health and Science, Molinette University Hospital, University of Turin
IP17-13: Negative Preoperative PSMA PET Does Not Rule Out Nodal Metastasis Identification by Pelvic Lymphadenectomy
Friday, May 15, 2026 1:00 PM to 3:00 PM
147A
IP17-14: Comparative Outcomes of Robotic Radical Prostatectomy Techniques: A Network Meta-Analysis of 5,641 Patients
Friday, May 15, 2026 1:00 PM to 3:00 PM
147A
IP17-15: Evaluating the Impact of Calculated Free Testosterone on Oncological Outcomes in Prostate Cancer Men Post Radical Prostatectomy
Friday, May 15, 2026 1:00 PM to 3:00 PM
147A
IP17-16: Impact of Primary Treatment Modalities on Survival in Ductal and Intraductal Prostate Carcinoma
Friday, May 15, 2026 1:00 PM to 3:00 PM
147A
IP17-17: Positive Surgical Margins Are Not Independently Associated with Biochemical Recurrence After Single Port Robot-Assisted Radical Prostatectomy: A Multi-Institutional Analysis from the Single Port Advanced Research Consortium (SPARC)
Friday, May 15, 2026 1:00 PM to 3:00 PM
147A
IP17-18: RADICAL PROSTATECTOMY VERSUS RADIATION WITH ANDROGEN DEPRIVATION THERAPY FOR CLINICAL LYMPH NODE POSITIVE PROSTATE CANCER: A CONTEMPORARY, SINGLE INSTITUTION SERIES WITH LANDMARK ANALYSIS
Friday, May 15, 2026 1:00 PM to 3:00 PM
147A
IP17-19: Significant Asymmetry in Positive Surgical Margins During Robot-Assisted Radical Prostatectomy: A Higher Incidence on the Left Side
Friday, May 15, 2026 1:00 PM to 3:00 PM
147A
Kaifeng Yao
IP17-20: Enhancing the Accuracy of PSMA-PET–Based Nomograms for Predicting Lymph Node Invasion in Prostate Cancer: The Added Value of Intraprostatic SUVmax
Friday, May 15, 2026 1:00 PM to 3:00 PM
147A
IP17-21: Robot-assisted radical prostatectomy with a suture less vesicourethral anastomosis using fibrin glue: a comparative clinical study
Friday, May 15, 2026 1:00 PM to 3:00 PM
147A
IP17-22: PSMA Radioguided Surgery for Predicting Tumor Location, Positive Surgical Margins and Local Staging in Prostate Cancer Patients Undergoing RARP with ePLND: Final Results of a Prospective Phase 2 Study
Friday, May 15, 2026 1:00 PM to 3:00 PM
147A
IP17-23: Impact of PSMA-PET on pelvic lymph node dissection trends in Australia: national compared to the largest single-centre cohort in Australia
Friday, May 15, 2026 1:00 PM to 3:00 PM
147A
IP17-24: Total Positive Margin Length as a Novel Prognostic Indicator After Radical Prostatectomy
Friday, May 15, 2026 1:00 PM to 3:00 PM
147A
IP17-25: A contemporary analysis of positive surgical margin length and oncologic outcomes after radical prostatectomy: results from an institutional registry with long-term follow up
Friday, May 15, 2026 1:00 PM to 3:00 PM
147A
IP17-26: Assessment of Patient Willingness to Travel for Specialized Care: A Case Study from a Tertiary Prostate Cancer Centre
Friday, May 15, 2026 1:00 PM to 3:00 PM
147A
IP17-27: Organ-specific side effects following curative-intent radiotherapy and radical prostatectomy for non-metastatic prostate cancer: A population-based cohort study
Friday, May 15, 2026 1:00 PM to 3:00 PM
147A
IP17-28: The Influence of Surgical Volume on Adverse Surgical Outcomes of Single Port Robotic Radical Prostatectomy: A Report from the Single Port Advanced Research Consortium (SPARC)
Friday, May 15, 2026 1:00 PM to 3:00 PM
147A
IP17-29: Oncological and functional outcomes following salvage robot assisted radical prostatectomy following radiation or ablation failure.
Friday, May 15, 2026 1:00 PM to 3:00 PM
147A
IP17-30: Single Port Transvesical Robotic Radical Prostatectomy: Comparison of Perioperative, Oncologic, and Functional Outcomes with the Multi-Port Transperitoneal Robotic Approach
Friday, May 15, 2026 1:00 PM to 3:00 PM
147A
